| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
14,258 |
12,623 |
$463K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,244 |
1,977 |
$112K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
548 |
517 |
$41K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
691 |
658 |
$34K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
316 |
280 |
$9K |
| 82962 |
|
1,734 |
1,564 |
$3K |
| 36416 |
|
1,887 |
1,691 |
$3K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
237 |
225 |
$3K |
| 99307 |
|
657 |
592 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
788 |
741 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
31 |
29 |
$2K |
| 99223 |
Prolong inpt eval add15 m |
38 |
26 |
$1K |
| 71046 |
Radiologic examination, chest; 2 views |
66 |
60 |
$1K |
| 99233 |
Prolong inpt eval add15 m |
64 |
12 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
78 |
72 |
$797.08 |
| 99334 |
|
141 |
123 |
$678.95 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
73 |
71 |
$536.19 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
24 |
23 |
$462.72 |
| 81003 |
|
240 |
231 |
$438.98 |
| 93000 |
|
25 |
22 |
$324.47 |
| 99051 |
|
12 |
12 |
$249.70 |